Lumicks

LUMICKS provides single-molecule analysis technologies for cancer research and immunotherapy.

Total raised

€97M

€97,255,100

Funding rounds

Investors

distinct backers

Active since

2021-04

latest 2024-10

Funding by year

EUR raised per year

High confidence

Raise-next likelihood28

base rate 45% for Debt

Exit likelihood16

base rate 12% (2+ rounds)

Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

2 rounds

Date	Stage	Amount	Investors
2024-10-10	Debt	€20M	European Investment Bank (EIB)	View deal →
2021-04-21	Other	€77M	—	View deal →

same sector or country